Macrogenics (MGNX) – Analyst Comments
-
TD Cowen Upgrades MacroGenics (MGNX) to Buy, 'We Believe There Is Favorable Risk/Reward Heading Into The Efficacy Update By The End Of May'
-
Stifel on MacroGenics (MGNX): 'incrementally more positive', 'We remain buyers into the next “by May 31” clinical update'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MGNX Stock Lookup